Artigo Acesso aberto Revisado por pares

NCCN Guidelines Insights: Colon Cancer, Version 2.2018

2018; National Comprehensive Cancer; Volume: 16; Issue: 4 Linguagem: Inglês

10.6004/jnccn.2018.0021

ISSN

1540-1413

Autores

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Ignacio Garrido‐Laguna, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass,

Tópico(s)

Genetic factors in colorectal cancer

Resumo

The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of

Referência(s)